logo-loader
RNS
viewOmega Diagnostics Group Plc

Result of General Meeting

/**/ h1{margin-right:0cm;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Verdana","sans-serif";color:#3B4FAE;}h2{margin-top:10.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:120%;font-size:13.0pt;font-family:"Cambria","serif";color:#4F81BD;}h3{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:center;font-size:11.0pt;font-family:"Times New Roman","serif";}h4{margin-top:2.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Cambria","serif";color:#365F91;font-weight:normal;font-div:italic;}h5{margin-top:2.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Cambria","serif";color:#365F91;font-weight:normal;}h6{margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;margin-left:144.0pt;text-align:justify;text-indent:-36.0pt;text-autospace:none;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight:normal;}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: purple } .ca{size:595.45pt 841.9pt;margin:60.0pt 70.1pt 21.1pt 70.35pt;}div.ca{}p.cr{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; margin-left: 0cm; margin-right: 1.35pt; margin-top: 0cm}p.cs{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; margin-left: 0cm; margin-right: 1.35pt; margin-top: 0cm; text-align: right}p.ct{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; margin-left: 0cm; margin-right: 1.35pt; margin-top: 0cm; text-align: center}span.cm{font-size:14.0pt;color:black; letter-spacing:-.4pt}span.cl{color:black;letter-spacing:-.4pt}span.ck{color:black}p.cu{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";line-height: normal; margin-bottom: 0cm; margin-left: 0cm; margin-right: 1.35pt; margin-top: 0cm; text-align: center}p.cv{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm} span.ci{font-size:18.0pt;color:black}p.cw{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal}p.cx{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: left}td.ce{width:230.25pt;padding:0cm 0cm 0cm 0cm}td.cc{width:223.25pt;padding:0cm 0cm 0cm 0cm}p.cy{margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-align:justify;line-height:120%;font-size:10.0pt;font-family:"Arial","sans-serif";line-height: normal; margin-bottom: 0cm; text-align: left}span.cb{font-size:12.0pt} /**/
RNS Number : 4831P
Omega Diagnostics Group PLC
10 October 2019
 

 

10 October 2019

 

Omega Diagnostics Group plc

("Omega" or the "Company")

 

Result of General Meeting

 

 

Further to Omega's announcement of 23 September 2019, the Company is pleased to announce the passing of the Resolutions at the General Meeting held earlier today. The Placing and Subscription remain conditional on Admission of the New Ordinary Shares to AIM which is expected to take place at 8.00 a.m. tomorrow.

 

With effect from Admission the Company will have 150,307,010 Ordinary Shares in issue, with no shares held in treasury. Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 23 September 2019.

 

Contacts:

Omega Diagnostics Group PLC            

Tel: 01259 763 030

 

www.omegadiagnostics.com

Colin King, Chief Executive Officer

Kieron Harbinson, Group Finance Director

 

Jag Grewal, Group Sales and Marketing Director                          

 

 

 

finnCap Ltd                        

Tel: 020 7220 0500

Geoff Nash/Hannah Boros (Corporate Finance)

 

Camille Gochez(ECM)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ROMKBLBFKBFLFBZ

Quick facts: Omega Diagnostics Group Plc

Price: 10.4

Market: AIM
Market Cap: £15.63 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE